References
- Curnutte, J. T. (1988). Classification of chronic granulomatous disease. Hematol Oncol Clin North Am, 2, 241–252.
- Segal, A. W. (1987). Absence of both cytochrome b-245 subunits from neutrophils in x-linked chronic granulomatous disease. Nature, 326, 88–91.
- Volpp, B. D., Nauseef, W. M. and Clark, R. A. (1988). Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science, 242, 1295–7.
- Di Bartolomeo, P., Di Girolamo, G., Angrilli, F., et al., (1989). Reconstitution of normal neutrophil function in chronic granulomatous disease by bone marrow transplantation. Bone Marrow Transplant, 4, 695–700.
- Nakamura, M., Murakami, M., Koga, T., Tanaka, J. and Minakami, S. (1987). Monoclonal antibody 7D5 raised to cytochrome b 558 of human neutrophils: immuno-cytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease and their carrier mother. Blood, 69, 1404–8.
- Segal, A. W. and Jones, O. T. G. (1979). The subcellular distribution and some properties of the cytochrome b component of the microbicidal oxidase system of human neutrophils. Biochem J, 182, 181–8.
- Ozsahin, H., Von Planta, M., Muller, I., Steinert, H. C., Nadal, D., Lauener, R., Tuchschmid, P., Willi, U. V., Ozsahin, M., Crompton, N. E. A. and Seger, R. A. (1998). Successful treatment of invasive Aspergillosis in Chronic Granulomatous Disease by Bone Marrow Transplantation, Granulocyte Colony-Stimulating Factor-Mobilized Granulocytes, and Lyposomal Amphotericin-B. Blood, 92, 1–7.
- Fischer, A., Segal, A. W., Seger, R. and Weening, R. S. (1993). The management of chronic granulomatous disease. Eur J Pediatr, 152, 896–9.
- Margolis, D. M., Medwick, D. A., Ailing, D. W. and Gallin, J. L. (1990). Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J Inf Dis, 162, 723–6.
- The International Chronic Granulomatous Disease Cooperative Study Group. (1991). A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. N Engl J Med, 324, 509–516.
- Fisher, A., Landais, A., Friedrich, B., et al., (1994). Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for immunodeficiency. Blood, 83, 1149–1154.
- Hassan, M., Ljungman, P., Bolme, P., et al., (1994). Busulfan bioavaibility. Blood, 84, 2144–2150.
- Di Bartolomeo, P., Di Girolamo, G., Olioso, P., et al., (1997). The Pescara experience of allogeneic bone marrow transplantation in thalassemia. Bone Marrow Transplant, 19(2), 48–53.